Expertise in
1
conditions

Stephen R. Macfarlane

Melbourne, VIC, AU 
Expertise in
1
conditions
Melbourne, VIC, AU 

Overview

Stephen Macfarlane practices practicing medicine in Melbourne, Australia.

Mr. Macfarlane is highly rated in 1 condition, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Vascular Dementia, and Frontotemporal Dementia.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Melbourne, VIC, Australia
Other Locations
Malvern, VIC, Australia
Clayton, VIC, Australia
Parkville, NSW, Australia
Wollongong, NSW, Australia
Sydney, NSW, Australia
VIC, Australia
Wembley, WA, Australia
Delmont, TAS, Australia
Caulfield, VIC, Australia
Greenwich, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2
View 2 Less Clinical Trials

43 Total Publications

Supporting the appropriate use of psychotropic medicines in aged and disability care.
Supporting the appropriate use of psychotropic medicines in aged and disability care.
Journal: Australian prescriber
Published: February 25, 2026

Frequently Asked Questions about Stephen R. Macfarlane

Is Stephen R. Macfarlane a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Stephen R. Macfarlane is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephen R. Macfarlane participate in research or clinical trials?

Yes. Stephen R. Macfarlane has published 43 articles and abstracts on conditions like Dementia. You can view a list of Stephen R. Macfarlane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Macfarlane's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile